Health News7 Min Read onSeptember 10, 2026 HHS’s Failure to Decarbonize the Healthcare Industry (Part 1) – The Health Care Blog By DAVID INTROCASO The Problem From an anthropocentric perspective, the climate crisis is fundamentally a threat to human health and…
Health News1 Min Read onSeptember 9, 2026 Mass General Brigham health plan drops MA coverage for Dana-Farber patients Listen to the article 1 min This audio is auto-generated. Please let us know if you have feedback. Mass General Brigham Health Plan has…
Health News4 Min Read onSeptember 8, 2026 How to Make Medicare Advantage Accountable – The Health Care Blog By FRANK LEAHY This is the second of two pieces. The first told the story of “Rick,” a 77-year-old Humana Medicare Advantage member who nearly…
Health News2 Min Read onSeptember 7, 2026 Adena Health acquires Fairfield Medical Center after antitrust scrutiny Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Adena Health has acquired…
Health News3 Min Read onSeptember 6, 2026 Lawmakers to subpoena Oracle execs as EHR project costs rise Dive Brief: The House Veterans Affairs Committee voted unanimously this week to subpoena two leaders at Oracle as costs mount for the…
Health News8 Min Read onSeptember 5, 2026 How a Medicare Advantage Runaround Nearly Cost a Senior His Sight – The Health Care Blog By FRANK LEAHY On a gray February morning, I sat in my office in Inverness, in rural northern California, with the phone pressed to my ear,…
Health News4 Min Read onSeptember 4, 2026 Why AI scribes are a malpractice risk, according to experts Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. Lured by promises of time savings and more…
onSeptember 3, 2026 The Pandemic Risk of “What I’ve Never Seen Before” – The Health Care Blog By MIKE MAGEE The world of medical science largely closed ranks last month in defense of Tony Fauci. Dr. Fauci had been hauled before the…
Health News2 Min Read onSeptember 2, 2026 Mid-cap biotechs join Trump’s latest round of drug pricing deals Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Nine mid-sized drugmakers have agreed to…